Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for CRANDELL KEITH
Goto 0, 1, 2, Next
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2022-10-24
Purchase
2022-10-26
8:01 pm
Prime Medicine Inc.PRMEARCH Venture Partners X LLC
ARCH Venture Partners X L.P.
ARCH Venture Partners X Overage L.P.
ARCH Venture Fund X L.P.
ARCH Venture Fund X Overage L.P.
CRANDELL KEITH
Burow Kristina
GILLIS STEVEN
10% Owner
800,000$17$13,600,0006,128,297
(Indirect)
View
2022-09-13
Purchase
2022-09-15
6:53 pm
Codiak BioSciences Inc.CDAKARCH Venture Fund VIII L.P.
ARCH Venture Fund VIII Overage L.P.
CRANDELL KEITH
BYBEE CLINTON
NELSEN ROBERT
ARCH Venture Partners VIII LLC
ARCH Venture Partners VIII L.P.
10% Owner
5,000,000$1.5$7,500,00013,854,098
(Indirect
Direct)
View
2021-08-12
Sale
2021-08-13
6:35 pm
Twist Bioscience CorpTWSTCRANDELL KEITH
Director
45,000$107.01$4,815,3771,172,002
(Indirect
Direct)
View
2021-07-30
Purchase
2021-08-03
9:12 pm
DA32 Life Science Tech Acquisition Corp.DALSCRANDELL KEITH
Director
10% Owner
1,600,000$10$16,000,0002,250,000
(Indirect)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2023-02-07
Option Award
2023-02-09
6:08 pm
N/A
N/A
Twist Bioscience CorpTWSTCRANDELL KEITH
Director
10% Owner
8,212$012,189
(Direct)
View
2023-01-03
Option Award
2023-01-04
4:03 pm
2023-12-31
2033-01-03
Quanterix CorpQTRXCRANDELL KEITH
Director
20,207$0142,190
(Direct)
View
2023-01-03
Option Award
2023-01-04
4:03 pm
N/A
N/A
Quanterix CorpQTRXCRANDELL KEITH
Director
1,015$12.86142,190
(Direct)
View
2022-10-24
Conversion
2022-10-26
8:01 pm
N/A
N/A
Prime Medicine Inc.PRMEARCH Venture Partners X LLC
ARCH Venture Partners X L.P.
ARCH Venture Partners X Overage L.P.
ARCH Venture Fund X L.P.
ARCH Venture Fund X Overage L.P.
CRANDELL KEITH
Burow Kristina
GILLIS STEVEN
10% Owner
41,344,576$06,128,297
(Indirect)
View

Ownership
2022-10-19
8:08 pm
N/A
N/A
Prime Medicine Inc.PRMEARCH Venture Partners X LLC
ARCH Venture Partners X L.P.
ARCH Venture Partners X Overage L.P.
ARCH Venture Fund X L.P.
ARCH Venture Fund X Overage L.P.
CRANDELL KEITH
Burow Kristina
GILLIS STEVEN
10% Owner
0$011,456,594
(Indirect)
View
2022-10-03
Option Award
2022-10-05
4:04 pm
N/A
N/A
Quanterix CorpQTRXCRANDELL KEITH
Director
1,326$10.48120,968
(Direct)
View
2022-09-02
Other
2022-09-07
8:29 pm
N/A
N/A
Vir Biotechnology Inc.VIRARCH Venture Partners IX LLC
ARCH Venture Partners IX L.P.
ARCH Venture Partners IX Overage L.P.
ARCH Venture Fund IX L.P.
ARCH Venture Fund IX Overage L.P.
CRANDELL KEITH
BYBEE CLINTON
10% Owner
1,035,018$01,126,748
(Indirect)
View
2022-08-30
Other
2022-09-01
5:20 pm
N/A
N/A
Vir Biotechnology Inc.VIRARCH Venture Partners IX LLC
ARCH Venture Partners IX L.P.
ARCH Venture Partners IX Overage L.P.
ARCH Venture Fund IX L.P.
ARCH Venture Fund IX Overage L.P.
CRANDELL KEITH
BYBEE CLINTON
10% Owner
1,035,006$01,117,864
(Indirect)
View
2022-08-24
Other
2022-08-26
5:12 pm
N/A
N/A
Vir Biotechnology Inc.VIRARCH Venture Partners IX LLC
ARCH Venture Partners IX L.P.
ARCH Venture Partners IX Overage L.P.
ARCH Venture Fund IX L.P.
ARCH Venture Fund IX Overage L.P.
CRANDELL KEITH
BYBEE CLINTON
10% Owner
1,035,006$01,109,010
(Indirect)
View
2022-08-18
Other
2022-08-22
5:14 pm
N/A
N/A
Vir Biotechnology Inc.VIRARCH Venture Partners IX LLC
ARCH Venture Partners IX L.P.
ARCH Venture Partners IX Overage L.P.
ARCH Venture Fund IX L.P.
ARCH Venture Fund IX Overage L.P.
CRANDELL KEITH
BYBEE CLINTON
10% Owner
517,503$0582,653
(Indirect)
View
2022-08-12
Other
2022-08-16
9:04 pm
N/A
N/A
Vir Biotechnology Inc.VIRARCH Venture Partners IX LLC
ARCH Venture Partners IX L.P.
ARCH Venture Partners IX Overage L.P.
ARCH Venture Fund IX L.P.
ARCH Venture Fund IX Overage L.P.
CRANDELL KEITH
BYBEE CLINTON
10% Owner
1,552,509$01,613,232
(Indirect)
View
2022-07-01
Option Award
2022-07-06
4:07 pm
N/A
N/A
Quanterix CorpQTRXCRANDELL KEITH
Director
10% Owner
893$16.79119,642
(Direct)
View
2022-06-15
Exercise
2022-06-17
4:15 pm
N/A
N/A
908 Devices Inc.MASSCRANDELL KEITH
Director
10% Owner
1,379$05,739,165
(Direct)
View
2022-06-16
Option Award
2022-06-17
4:15 pm
N/A
N/A
908 Devices Inc.MASSCRANDELL KEITH
Director
10% Owner
12,741$05,739,165
(Direct)
View
2022-06-08
Other
2022-06-10
9:27 pm
N/A
N/A
Vir Biotechnology Inc.VIRARCH Venture Partners IX LLC
ARCH Venture Partners IX L.P.
ARCH Venture Partners IX Overage L.P.
ARCH Venture Fund IX L.P.
ARCH Venture Fund IX Overage L.P.
CRANDELL KEITH
BYBEE CLINTON
10% Owner
517,503$0564,945
(Indirect)
View
2022-06-02
Other
2022-06-06
8:24 pm
N/A
N/A
Vir Biotechnology Inc.VIRARCH Venture Partners IX LLC
ARCH Venture Partners IX L.P.
ARCH Venture Partners IX Overage L.P.
ARCH Venture Fund IX L.P.
ARCH Venture Fund IX Overage L.P.
CRANDELL KEITH
BYBEE CLINTON
10% Owner
517,502$010,955,581
(Indirect)
View
2022-04-01
Option Award
2022-04-05
4:42 pm
N/A
N/A
Quanterix CorpQTRXCRANDELL KEITH
Director
10% Owner
492$30.47118,749
(Direct)
View
2022-02-08
Option Award
2022-02-10
7:32 pm
N/A
N/A
Twist Bioscience CorpTWSTCRANDELL KEITH
Director
3,491$080,024
(Direct)
View
2021-11-16
Other
2022-01-05
4:06 pm
N/A
N/A
Quanterix CorpQTRXCRANDELL KEITH
Director
10% Owner
619,520$0741,779
(Indirect)
View
2022-01-03
Option Award
2022-01-05
4:06 pm
N/A
N/A
Quanterix CorpQTRXCRANDELL KEITH
Director
10% Owner
307$42.41741,779
(Direct)
View
2022-01-03
Option Award
2022-01-05
4:06 pm
2022-12-31
2032-01-03
Quanterix CorpQTRXCRANDELL KEITH
Director
10% Owner
6,670$0741,779
(Direct)
View
2021-12-20
Other
2021-12-22
5:59 pm
N/A
N/A
Vir Biotechnology Inc.VIRARCH Venture Partners IX LLC
ARCH Venture Partners IX L.P.
ARCH Venture Partners IX Overage L.P.
ARCH Venture Fund IX L.P.
ARCH Venture Fund IX Overage L.P.
CRANDELL KEITH
BYBEE CLINTON
10% Owner
1,811,207$012,527,079
(Indirect)
View
2021-11-29
Other
2021-12-01
6:30 pm
N/A
N/A
Vir Biotechnology Inc.VIRARCH Venture Partners IX LLC
ARCH Venture Partners IX L.P.
ARCH Venture Partners IX Overage L.P.
ARCH Venture Fund IX L.P.
ARCH Venture Fund IX Overage L.P.
CRANDELL KEITH
BYBEE CLINTON
10% Owner
517,485$012,205,620
(Indirect)
View
2021-11-22
Other
2021-11-24
5:58 pm
N/A
N/A
Vir Biotechnology Inc.VIRARCH Venture Partners IX LLC
ARCH Venture Partners IX L.P.
ARCH Venture Partners IX Overage L.P.
ARCH Venture Fund IX L.P.
ARCH Venture Fund IX Overage L.P.
CRANDELL KEITH
BYBEE CLINTON
10% Owner
517,485$012,483,411
(Indirect)
View
2021-08-10
Other
2021-10-05
4:02 pm
N/A
N/A
Quanterix CorpQTRXCRANDELL KEITH
Director
10% Owner
639,906$0969,610
(Indirect)
View
2021-10-01
Option Award
2021-10-05
4:02 pm
N/A
N/A
Quanterix CorpQTRXCRANDELL KEITH
Director
10% Owner
254$51.18969,610
(Direct)
View
2021-02-11
Other
2021-08-13
6:35 pm
N/A
N/A
Twist Bioscience CorpTWSTCRANDELL KEITH
Director
1,051,881$01,172,002
(Indirect)
View
2021-08-05
Disposition
2021-08-09
8:35 pm
N/A
N/A
DA32 Life Science Tech Acquisition Corp.DALSCRANDELL KEITH
Director
10% Owner
701,250$04,495,000
(Indirect)
View
2021-07-30
Option Award
2021-08-03
9:12 pm
N/A
N/A
DA32 Life Science Tech Acquisition Corp.DALSCRANDELL KEITH
Director
10% Owner
650,000$102,250,000
(Indirect)
View

Ownership
2021-07-27
9:51 pm
N/A
N/A
DA32 Life Science Tech Acquisition Corp.DALSCRANDELL KEITH
Director
10% Owner
0$05,196,250
(Direct)
View
2021-07-20
Conversion
2021-07-20
8:53 pm
N/A
N/A
Erasca Inc.ERASARCH Venture Partners X LLC
ARCH Venture Fund X L.P.
ARCH Venture Fund X Overage L.P.
ARCH Venture Partners X L.P.
ARCH Venture Partners X Overage L.P.
NELSEN ROBERT
CRANDELL KEITH
Burow Kristina
GILLIS STEVEN
10% Owner
18,794,443$05,527,777
(Indirect)
View

Ownership
2021-07-15
9:06 pm
N/A
N/A
Erasca Inc.ERASARCH Venture Partners X LLC
ARCH Venture Fund X L.P.
ARCH Venture Fund X Overage L.P.
ARCH Venture Partners X L.P.
ARCH Venture Partners X Overage L.P.
NELSEN ROBERT
CRANDELL KEITH
Burow Kristina
GILLIS STEVEN
10% Owner
0$011,055,554
(Indirect)
View
2021-07-01
Option Award
2021-07-06
5:17 pm
N/A
N/A
Quanterix CorpQTRXCRANDELL KEITH
Director
218$59.481,634,632
(Direct)
View
2021-05-13
Other
2021-07-06
5:17 pm
N/A
N/A
Quanterix CorpQTRXCRANDELL KEITH
Director
1,083,710$01,634,632
(Indirect)
View
2021-03-09
Other(A)
2021-07-06
5:17 pm
N/A
N/A
Quanterix CorpQTRXCRANDELL KEITH
Director
877,287$01,803,061
(Indirect)
View
2021-04-01
Option Award(A)
2021-07-06
5:17 pm
N/A
N/A
Quanterix CorpQTRXCRANDELL KEITH
Director
211$61.451,803,061
(Direct)
View
2021-07-01
Other
2021-07-06
4:47 pm
N/A
N/A
Vir Biotechnology Inc.VIRARCH Venture Partners IX LLC
ARCH Venture Partners IX L.P.
ARCH Venture Partners IX Overage L.P.
ARCH Venture Fund IX L.P.
ARCH Venture Fund IX Overage L.P.
CRANDELL KEITH
BYBEE CLINTON
10% Owner
4,033,412$016,277,129
(Indirect)
View
2021-06-30
Other
2021-07-02
5:19 pm
N/A
N/A
Beam Therapeutics Inc.BEAMARCH Venture Partners IX LLC
ARCH Venture Partners IX L.P.
ARCH Venture Partners IX Overage L.P.
ARCH Venture Fund IX L.P.
ARCH Venture Fund IX Overage L.P.
CRANDELL KEITH
BYBEE CLINTON
NELSEN ROBERT
10% Owner
208,052$03,357,682
(Indirect)
View
2021-06-25
Other
2021-06-29
5:22 pm
N/A
N/A
Beam Therapeutics Inc.BEAMARCH Venture Partners IX LLC
ARCH Venture Partners IX L.P.
ARCH Venture Partners IX Overage L.P.
ARCH Venture Fund IX L.P.
ARCH Venture Fund IX Overage L.P.
CRANDELL KEITH
BYBEE CLINTON
NELSEN ROBERT
10% Owner
416,104$03,961,048
(Indirect)
View
2021-06-22
Other
2021-06-24
5:03 pm
N/A
N/A
Vir Biotechnology Inc.VIRARCH Venture Partners IX LLC
ARCH Venture Partners IX L.P.
ARCH Venture Partners IX Overage L.P.
ARCH Venture Fund IX L.P.
ARCH Venture Fund IX Overage L.P.
CRANDELL KEITH
BYBEE CLINTON
10% Owner
1,008,348$015,501,684
(Indirect)
View
2021-06-21
Conversion
2021-06-23
5:42 pm
N/A
N/A
Lyell Immunopharma Inc.LYELARCH Venture Partners IX LLC
ARCH Venture Fund IX Overage L.P.
ARCH Venture Fund IX L.P.
ARCH Venture Partners IX Overage L.P.
ARCH Venture Partners IX L.P.
CRANDELL KEITH
BYBEE CLINTON
10% Owner
54,619,074$018,206,358
(Indirect)
View
2021-06-21
Conversion
2021-06-23
4:29 pm
N/A
N/A
Verve Therapeutics Inc.VERVARCH Venture Partners X LLC
ARCH Venture Fund X L.P.
ARCH Venture Fund X Overage L.P.
ARCH Venture Partners X L.P.
ARCH Venture Partners X Overage L.P.
CRANDELL KEITH
NELSEN ROBERT
Burow Kristina
GILLIS STEVEN
10% Owner
25,739,146$01,254,405
(Indirect)
View
2021-06-17
Option Award
2021-06-21
08:07 am
N/A
2031-06-17
908 Devices Inc.MASSCRANDELL KEITH
Director
10% Owner
3,834$03,834
(Direct)
View

Ownership
2021-06-16
9:00 pm
N/A
N/A
Lyell Immunopharma Inc.LYELARCH Venture Partners IX LLC
ARCH Venture Fund IX L.P.
ARCH Venture Fund IX Overage L.P.
ARCH Venture Partners IX Overage L.P.
ARCH Venture Partners IX L.P.
CRANDELL KEITH
BYBEE CLINTON
10% Owner
0$036,412,716
(Indirect)
View

Ownership
2021-06-16
7:35 pm
N/A
N/A
Verve Therapeutics Inc.VERVARCH Venture Fund X L.P.
ARCH Venture Fund X Overage L.P.
ARCH Venture Partners X L.P.
ARCH Venture Partners X Overage L.P.
ARCH Venture Partners X LLC
CRANDELL KEITH
NELSEN ROBERT
Burow Kristina
GILLIS STEVEN
10% Owner
0$02,508,809
(Indirect)
View
2021-04-13
Other
2021-04-15
5:18 pm
N/A
N/A
Karuna Therapeutics Inc.KRTXARCH Venture Partners IX LLC
ARCH Venture Partners IX L.P.
ARCH Venture Partners IX Overage L.P.
ARCH Venture Fund IX L.P.
ARCH Venture Fund IX Overage L.P.
BYBEE CLINTON
CRANDELL KEITH
10% Owner
76,264$01,608,617
(Indirect)
View
(A) Indicate amendment filing.
Goto 0, 1, 2, Next